
---
title: '华海药业：阿哌沙班片获得药品注册证书'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=4386'
author: 证券时报网
comments: false
date: Mon, 09 May 2022 16:48:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4386'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600521" style="color: #2f67d1;text-decoration: none;" code="600521" target="_blank">华海药业</a>(600521)5月9日晚间公告，公司阿哌沙班片获得国家药监局签发药品注册证书，阿哌沙班片主要用于降低中风和全身性栓塞风险。本次获批标志着公司具备了在国内市场销售该药品的资格。</p>

                  
</div>
            